Elaine K. Sorg, SVP, US COMMERCIAL OPERATIONS at AbbVie Inc. (ABBV), sold 6,130 shares at $165.00 ($1.0M) on 2023-04-25, disclosed to the SEC on 2023-04-27.
Scheduled sale ($1.0M) by SVP, US COMMERCIAL OPERATIONS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABBV | SELL | 2023-03-02 | $2.3M | — | Filing → |
| ABBV | SELL | 2023-02-21 | $4.6M | — | Filing → |
| ABBV | SELL | 2022-03-01 | $1.8M | — | Filing → |